Cholesterol is a structural component of cellular membranes particularly enriched in synapses but its role in synaptic transmission remains poorly understood. We used rat hippocampal cultures and their acute cholesterol depletion by methyl-β-cyclodextrin as a tool to describe the physiological role of cholesterol in glutamatergic synaptic transmission. Cholesterol proved to be a key molecule for the function of synapses as its depletion resulted in a significant reduction of both NMDA receptor (NMDAR) and AMPA/kainate receptor-mediated evoked excitatory postsynaptic currents (eEPSCs), by 94% and 72%, respectively. We identified two presynaptic and two postsynaptic steps of synaptic transmission which are modulated by cholesterol and explain together the above-mentioned reduction of eEPSCs. In the postsynapse, we show that physiological levels of cholesterol are important for maintaining the normal probability of opening of NMDARs and for keeping NMDARs localized in synapses. In the presynapse, our results favour the hypothesis of a role of cholesterol in the propagation of axonal action potentials. Finally, cholesterol is a negative modulator of spontaneous presynaptic glutamate release. Our study identifies cholesterol as an important endogenous regulator of synaptic transmission and provides insight into molecular mechanisms underlying the neurological manifestation of diseases associated with impaired cholesterol synthesis or decomposition.

Department of Cellular Neurophysiology Institute of Physiology of the Czech Academy of Sciences Videnska 1083 Prague Czech Republic

School of Pharmacy and Biomedical Sciences University of Central Lancashire Preston UK

Zobrazit více v PubMed

Carta M, et al. Membrane lipids tune synaptic transmission by direct modulation of presynaptic potassium channels. Neuron. 2014;81:787–799. doi: 10.1016/j.neuron.2013.12.028. PubMed DOI

Egawa J, Pearn ML, Lemkuil BP, Patel PM, Head BP. Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function. J. Physiol. 2016;594:4565–4579. doi: 10.1113/JP270590. PubMed DOI PMC

Korinek M, et al. Cholesterol modulates open probability and desensitization of NMDA receptors. J. Physiol. 2015;593:2279–2293. doi: 10.1113/jphysiol.2014.288209. PubMed DOI PMC

Lauwers E, Goodchild R, Verstreken P. Membrane lipids in presynaptic function and disease. Neuron. 2016;90:11–25. doi: 10.1016/j.neuron.2016.02.033. PubMed DOI

Renner M, Choquet D, Triller A. Control of the postsynaptic membrane viscosity. J. Neurosci. 2009;29:2926–2937. doi: 10.1523/JNEUROSCI.4445-08.2009. PubMed DOI PMC

Puchkov D, Haucke V. Greasing the synaptic vesicle cycle by membrane lipids. Trends Cell Biol. 2013;23:493–503. doi: 10.1016/j.tcb.2013.05.002. PubMed DOI

Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. Faseb J. 2001;15:1858–1860. doi: 10.1096/fj.00-0815fje. PubMed DOI

Frank C, et al. Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp.. Neurol. 2008;212:407–414. doi: 10.1016/j.expneurol.2008.04.019. PubMed DOI

Maggo S, Ashton JC. Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig. Eur. J. Pharmacol. 2014;723:294–304. doi: 10.1016/j.ejphar.2013.11.018. PubMed DOI

Brachet A, et al. LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic delivery. J. Cell Biol. 2015;208:791–806. doi: 10.1083/jcb.201407122. PubMed DOI PMC

Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6:254–264. doi: 10.1007/s13238-014-0131-3. PubMed DOI PMC

Dietschy JM. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 2009;390:287–293. doi: 10.1515/BC.2009.035. PubMed DOI PMC

Ledesma MD, Martin MG, Dotti CG. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog. Lipid Res. 2012;51:23–35. doi: 10.1016/j.plipres.2011.11.004. PubMed DOI

Cibickova L. Statins and their influence on brain cholesterol. J. Clin. Lipidol. 2011;5:373–379. doi: 10.1016/j.jacl.2011.06.007. PubMed DOI

Liu B, et al. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc. Natl. Acad. Sci. USA. 2009;106:2377–2382. doi: 10.1073/pnas.0810895106. PubMed DOI PMC

Tint GS, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 1994;330:107–113. doi: 10.1056/NEJM199401133300205. PubMed DOI

Berry-Kravis E, et al. Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-beta-Cyclodextrin. Pediatr Neurol. 2018;80:24–34. doi: 10.1016/j.pediatrneurol.2017.12.014. PubMed DOI PMC

Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim. Biophys. Acta. 2007;1768:1311–1324. doi: 10.1016/j.bbamem.2007.03.026. PubMed DOI PMC

Lopez CA, de Vries AH, Marrink SJ. Computational microscopy of cyclodextrin mediated cholesterol extraction from lipid model membranes. Sci Rep. 2013;3:2071. doi: 10.1038/srep02071. PubMed DOI PMC

Wollmuth LP. Ion permeation in ionotropic glutamate receptors: Still dynamic after all these years. Curr. Opin. Physiol. 2018;2:36–41. doi: 10.1016/j.cophys.2017.12.003. PubMed DOI PMC

Traynelis SF, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010;62:405–496. doi: 10.1124/pr.109.002451. PubMed DOI PMC

Rosenmund C, Feltz A, Westbrook GL. Synaptic NMDA receptor channels have a low open probability. J. Neurosci. 1995;15:2788–2795. doi: 10.1523/JNEUROSCI.15-04-02788.1995. PubMed DOI PMC

Tovar KR, Westbrook GL. Mobile NMDA receptors at hippocampal synapses. Neuron. 2002;34:255–264. doi: 10.1016/S0896-6273(02)00658-X. PubMed DOI

Jahr CE. High probability opening of NMDA receptor channels by L-glutamate. Science. 1992;255:470–472. doi: 10.1126/science.1346477. PubMed DOI

Vyklicky, V. et al. in Neuromethods Vol. 106 Neuromethods (ed G. K. Popescu) 205–219 (Humana Press Inc, Totowa, 2016).

Naisbitt S, et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron. 1999;23:569–582. doi: 10.1016/s0896-6273(00)80809-0. PubMed DOI

Petralia RS, et al. Selective acquisition of AMPA receptors over postnatal development suggests a molecular basis for silent synapses. Nat. Neurosci. 1999;2:31–36. doi: 10.1038/4532. PubMed DOI

Hahn J, Wang X, Margeta M. Astrocytes increase the activity of synaptic GluN2B NMDA receptors. Front. Cell. Neurosci. 2015;9:117. doi: 10.3389/fncel.2015.00117. PubMed DOI PMC

Capogna M, Gahwiler BH, Thompson SM. Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J. Neurophysiol. 1996;75:2017–2028. doi: 10.1152/jn.1996.75.5.2017. PubMed DOI

Sobieski C, Jiang X, Crawford DC, Mennerick S. Loss of local astrocyte support disrupts action potential propagation and glutamate release synchrony from unmyelinated hippocampal axon terminals in vitro. J. Neurosci. 2015;35:11105–11117. doi: 10.1523/JNEUROSCI.1289-15.2015. PubMed DOI PMC

Oleskevich S, Clements J, Walmsley B. Release probability modulates short-term plasticity at a rat giant terminal. J. Physiol. 2000;524(Pt 2):513–523. doi: 10.1111/j.1469-7793.2000.00513.x. PubMed DOI PMC

Ponce J, et al. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke. 2008;39:1269–1275. doi: 10.1161/STROKEAHA.107.498923. PubMed DOI

Zacco A, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 2003;23:11104–11111. doi: 10.1523/JNEUROSCI.23-35-11104.2003. PubMed DOI PMC

Amico-Ruvio SA, Popescu GK. Stationary gating of GluN1/GluN2B receptors in intact membrane patches. Biophys. J. 2010;98:1160–1169. doi: 10.1016/j.bpj.2009.12.4276. PubMed DOI PMC

Ladislav M, et al. The LILI motif of M3–S2 linkers is a component of the NMDA receptor channel gate. Front. Mol. Neurosci. 2018;11:113. doi: 10.3389/fnmol.2018.00113. PubMed DOI PMC

Williams SR, Mitchell SJ. Direct measurement of somatic voltage clamp errors in central neurons. Nat. Neurosci. 2008;11:790–798. doi: 10.1038/nn.2137. PubMed DOI

Linsenbardt AJ, et al. Different oxysterols have opposing actions at N-methyl-d-aspartate receptors. Neuropharmacology. 2014;85C:232–242. doi: 10.1016/j.neuropharm.2014.05.027. PubMed DOI PMC

Paul SM, et al. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J. Neurosci. 2013;33:17290–17300. doi: 10.1523/JNEUROSCI.2619-13.2013. PubMed DOI PMC

Frank C, Giammarioli AM, Pepponi R, Fiorentini C, Rufini S. Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Lett. 2004;566:25–29. doi: 10.1016/j.febslet.2004.03.113. PubMed DOI

Smith AJ, Sugita S, Charlton MP. Cholesterol-dependent kinase activity regulates transmitter release from cerebellar synapses. J. Neurosci. 2010;30:6116–6121. doi: 10.1523/JNEUROSCI.0170-10.2010. PubMed DOI PMC

Wasser CR, Ertunc M, Liu X, Kavalali ET. Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling. J. Physiol. 2007;579:413–429. doi: 10.1113/jphysiol.2006.123133. PubMed DOI PMC

Dason JS, Smith AJ, Marin L, Charlton MP. Vesicular sterols are essential for synaptic vesicle cycling. J. Neurosci. 2010;30:15856–15865. doi: 10.1523/JNEUROSCI.4132-10.2010. PubMed DOI PMC

Dason JS, Smith AJ, Marin L, Charlton MP. Cholesterol and F-actin are required for clustering of recycling synaptic vesicle proteins in the presynaptic plasma membrane. J. Physiol. 2014;592:621–633. doi: 10.1113/jphysiol.2013.265447. PubMed DOI PMC

Bruckner RJ, Mansy SS, Ricardo A, Mahadevan L, Szostak JW. Flip-flop-induced relaxation of bending energy: implications for membrane remodeling. Biophys. J. 2009;97:3113–3122. doi: 10.1016/j.bpj.2009.09.025. PubMed DOI PMC

Zamir O, Charlton MP. Cholesterol and synaptic transmitter release at crayfish neuromuscular junctions. J. Physiol. 2006;571:83–99. doi: 10.1113/jphysiol.2005.098319. PubMed DOI PMC

Sara Y, Virmani T, Deak F, Liu X, Kavalali ET. An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neuron. 2005;45:563–573. doi: 10.1016/j.neuron.2004.12.056. PubMed DOI

Pekala D, Szkudlarek H, Raastad M. Typical gray matter axons in mammalian brain fail to conduct action potentials faithfully at fever-like temperatures. Physiol. Rep. 2016 doi: 10.14814/phy2.12981. PubMed DOI PMC

Abulrob A, et al. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J. Neurochem. 2005;92:1477–1486. doi: 10.1111/j.1471-4159.2005.03001.x. PubMed DOI

Banach M, et al. Intensive LDL-cholesterol lowering therapy and neurocognitive function. Pharmacol. Ther. 2017;170:181–191. doi: 10.1016/j.pharmthera.2016.11.001. PubMed DOI

Hong KS, Lee JS. Statins in acute ischemic stroke: a systematic review. J. Stroke. 2015;17:282–301. doi: 10.5853/jos.2015.17.3.282. PubMed DOI PMC

Vanier MT. Niemann-Pick disease type C. Orphanet J. Rare Dis. 2010;5:16. doi: 10.1186/1750-1172-5-16. PubMed DOI PMC

Davidson CD, et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE. 2009;4:e6951. doi: 10.1371/journal.pone.0006951. PubMed DOI PMC

Crumling MA, King KA, Duncan RK. Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk. Front Cell Neurosci. 2017;11:355. doi: 10.3389/fncel.2017.00355. PubMed DOI PMC

Peng Y, Myers R, Zhang W, Alexov E. Computational investigation of the missense mutations in DHCR7 gene associated with Smith-Lemli-Opitz syndrome. Int. J. Mol. Sci. 2018 doi: 10.3390/ijms19010141. PubMed DOI PMC

Saskin A, Fulginiti V, Birch AH, Trakadis Y. Prevalence of four Mendelian disorders associated with autism in 2392 affected families. J. Hum. Genet. 2017;62:657–659. doi: 10.1038/jhg.2017.16. PubMed DOI

Vyklicky V, et al. Surface expression, function, and pharmacology of disease-associated mutations in the membrane domain of the human GluN2B subunit. Front. Mol. Neurosci. 2018;11:110. doi: 10.3389/fnmol.2018.00110. PubMed DOI PMC

Burgalossi A, et al. Analysis of neurotransmitter release mechanisms by photolysis of caged Ca(2)(+) in an autaptic neuron culture system. Nat. Protoc. 2012;7:1351–1365. doi: 10.1038/nprot.2012.074. PubMed DOI

Gonzalez-Gonzalez IM, Henley JM. Postsynaptic kainate receptor recycling and surface expression are regulated by metabotropic autoreceptor signalling. Traffic. 2013;14:810–822. doi: 10.1111/tra.12071. PubMed DOI PMC

Korinek M, Sedlacek M, Cais O, Dittert I, Vyklicky L., Jr Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents. Neuroscience. 2010;165:736–748. doi: 10.1016/j.neuroscience.2009.10.058. PubMed DOI

Jahr CE, Stevens CF. Calcium permeability of the N-methyl-D-aspartate receptor channel in hippocampal neurons in culture. Proc. Natl. Acad. Sci. USA. 1993;90:11573–11577. doi: 10.1073/pnas.90.24.11573. PubMed DOI PMC

Dupuis JP, et al. Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses. Embo J. 2014;33:842–861. doi: 10.1002/embj.201386356. PubMed DOI PMC

Mikasova L, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain. 2012;135:1606–1621. doi: 10.1093/brain/aws092. PubMed DOI

Morini R, et al. Lack of the actin capping protein, Eps8, affects NMDA-Type glutamate receptor function and composition. Front. Mol. Neurosci. 2018;11:313. doi: 10.3389/fnmol.2018.00313. PubMed DOI PMC

Zhang H, et al. Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington's disease models. Nat. Commun. 2018;9:4272. doi: 10.1038/s41467-018-06675-3. PubMed DOI PMC

Stanic J, et al. Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex. Nat. Commun. 2015;6:10181. doi: 10.1038/ncomms10181. PubMed DOI PMC

Yokoi N, et al. Identification of PSD-95 depalmitoylating enzymes. J. Neurosci. 2016;36:6431–6444. doi: 10.1523/JNEUROSCI.0419-16.2016. PubMed DOI PMC

Groc L, et al. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl. Acad. Sci. USA. 2006;103:18769–18774. doi: 10.1073/pnas.0605238103. PubMed DOI PMC

Liu J, et al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano. 2010;4:2755–2765. doi: 10.1021/nn100213v. PubMed DOI PMC

Tinevez JY, et al. TrackMate: an open and extensible platform for single-particle tracking. Methods. 2017;115:80–90. doi: 10.1016/j.ymeth.2016.09.016. PubMed DOI

Ehlers MD, Heine M, Groc L, Lee MC, Choquet D. Diffusional trapping of GluR1 AMPA receptors by input-specific synaptic activity. Neuron. 2007;54:447–460. doi: 10.1016/j.neuron.2007.04.010. PubMed DOI PMC

Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006;224:213–232. doi: 10.1111/j.1365-2818.2006.01706.x. PubMed DOI

Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology